ONTOLOGY REPORT - ANNOTATIONS
Term: docetaxel anhydrous
Accession: CHEBI:4672
browse the term
Definition: A tetracyclic diterpenoid that is paclitaxel with the N-benzyloxycarbonyl group replaced by N-tert-butoxycarbonyl, and the acetoxy group at position 10 replaced by a hydroxy group.
Synonyms: exact_synonym: 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
related_synonym: C43H53NO14; Docetaxel; InChI=1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1; InChIKey=ZDZOTLJHXYCWBA-VCVYQWHSSA-N; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel; N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol; TXL; [H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c1ccccc1
xref_casrn: 114977-28-5
xref: Beilstein:4290183 "Beilstein Registry Number"; ChEMBL:109097 "ChEMBL COMPOUND"; ChemIDplus:114977-28-5 "CAS Registry Number"; DrugBank:DB01248 "DrugBank"; KEGG COMPOUND:114977-28-5 "CAS Registry Number"; KEGG COMPOUND:C11231 "KEGG COMPOUND"; KEGG DRUG:D07866 "KEGG DRUG"
xref_mesh: MESH:C067311
xref: Patent:EP253738 "Patent"; Patent:US4814470 "Patent"; Wikipedia:Docetaxel "Wikipedia"
docetaxel anhydrous
G
Abca1
ATP-binding cassette, subfamily A (ABC1), member 1
multiple interactions
ISO
5
70,493,357
70,583,729
RGD:6480464
CTD
G
Abca12
ATP-binding cassette, subfamily A (ABC1), member 12
multiple interactions
ISO
9
70,328,327
70,501,128
RGD:6480464
CTD
G
Abca3
ATP-binding cassette, subfamily A (ABC1), member 3
multiple interactions
ISO
10
13,619,865
13,665,066
RGD:6480464
CTD
G
Abca4
ATP-binding cassette, subfamily A (ABC1), member 4
multiple interactions
ISO
2
218,712,663
218,849,896
RGD:6480464
CTD
G
Abca5
ATP-binding cassette, subfamily A (ABC1), member 5
multiple interactions
ISO
10
99,724,778
99,793,593
RGD:6480464
CTD
G
Abca6
ATP-binding cassette, subfamily A (ABC1), member 6
multiple interactions
ISO
10
99,626,334
99,693,870
RGD:6480464
CTD
G
Abca7
ATP-binding cassette, subfamily A (ABC1), member 7
multiple interactions
ISO
7
11,203,983
11,222,960
RGD:6480464
CTD
G
Abca8
ATP-binding cassette, subfamily A (ABC1), member 8
multiple interactions
ISO
10
99,392,053
99,452,833
RGD:6480464
CTD
G
Abca9
ATP-binding cassette, subfamily A (ABC1), member 9
multiple interactions
ISO
10
99,558,803
99,619,870
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
multiple interactions
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
decreases response to substance
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
increases expression
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
increases expression
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
increases response to substance
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
increases expression
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
multiple interactions
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
multiple interactions
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
decreases expression
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
multiple interactions
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
decreases response to substance
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Abcb4
ATP-binding cassette, subfamily B (MDR/TAP), member 4
multiple interactions
ISO
4
21,946,274
22,004,328
RGD:6480464
CTD
G
Abcb6
ATP-binding cassette, subfamily B (MDR/TAP), member 6
multiple interactions
ISO
9
74,454,805
74,463,083
RGD:6480464
CTD
G
Abcb8
ATP-binding cassette, subfamily B (MDR/TAP), member 8
multiple interactions
ISO
4
6,133,928
6,148,509
RGD:6480464
CTD
G
Abcc1
ATP-binding cassette, subfamily C (CFTR/MRP), member 1
increases expression
ISO
10
452,239
575,705
RGD:6480464
CTD
G
Abcc1
ATP-binding cassette, subfamily C (CFTR/MRP), member 1
multiple interactions
ISO
10
452,239
575,705
RGD:6480464
CTD
G
Abcc10
ATP-binding cassette, subfamily C (CFTR/MRP), member 10
multiple interactions
ISO
9
10,219,822
10,239,734
RGD:6480464
CTD
G
Abcc2
ATP-binding cassette, subfamily C (CFTR/MRP), member 2
affects transport
ISO
RGD:6480464
CTD
G
Abcc2
ATP-binding cassette, subfamily C (CFTR/MRP), member 2
multiple interactions
ISO
RGD:6480464
CTD
G
Abcc2
ATP-binding cassette, subfamily C (CFTR/MRP), member 2
multiple interactions
ISO
RGD:6480464
CTD
G
Abcc3
ATP-binding cassette, subfamily C (CFTR/MRP), member 3
multiple interactions
ISO
10
82,986,552
83,030,799
RGD:6480464
CTD
G
Abcc4
ATP-binding cassette, subfamily C (CFTR/MRP), member 4
multiple interactions
ISO
15
103,384,848
103,611,238
RGD:6480464
CTD
G
Abcc5
ATP-binding cassette, subfamily C (CFTR/MRP), member 5
multiple interactions
ISO
11
82,714,334
82,809,354
RGD:6480464
CTD
G
Abcc6
ATP-binding cassette, subfamily C (CFTR/MRP), member 6
multiple interactions
ISO
1
96,448,588
96,524,655
RGD:6480464
CTD
G
Abcc9
ATP-binding cassette, subfamily C (CFTR/MRP), member 9
multiple interactions
ISO
RGD:6480464
CTD
G
Abcd2
ATP-binding cassette, subfamily D (ALD), member 2
multiple interactions
ISO
7
129,542,758
129,591,363
RGD:6480464
CTD
G
Abce1
ATP-binding cassette, subfamily E (OABP), member 1
multiple interactions
ISO
19
30,093,741
30,118,625
RGD:6480464
CTD
G
Abcg2
ATP-binding cassette, subfamily G (WHITE), member 2
multiple interactions
ISO
4
87,502,584
87,560,017
RGD:6480464
CTD
G
Aco2
aconitase 2, mitochondrial
multiple interactions
ISO
7
120,223,788
120,266,944
RGD:6480464
CTD
G
Akt1
v-akt murine thymoma viral oncogene homolog 1
multiple interactions
ISO
6
137,640,482
137,657,552
RGD:6480464
CTD
G
Akt1
v-akt murine thymoma viral oncogene homolog 1
decreases phosphorylation
ISO
6
137,640,482
137,657,552
RGD:6480464
CTD
G
Aldoa
aldolase A, fructose-bisphosphate
multiple interactions
ISO
1
185,970,658
185,974,615
RGD:6480464
CTD
G
Ar
androgen receptor
multiple interactions
ISO
X
85,949,507
86,119,199
RGD:6480464
CTD
G
Ar
androgen receptor
decreases localization
ISO
X
85,949,507
86,119,199
RGD:6480464
CTD
G
Bad
BCL2-associated agonist of cell death
decreases phosphorylation
ISO
1
209,617,373
209,626,292
RGD:6480464
CTD
G
Bad
BCL2-associated agonist of cell death
multiple interactions
ISO
1
209,617,373
209,626,292
RGD:6480464
CTD
G
Bak1
BCL2-antagonist/killer 1
multiple interactions
ISO
20
5,255,954
5,264,593
RGD:6480464
CTD
G
Bak1
BCL2-antagonist/killer 1
multiple interactions
ISO
20
5,255,954
5,264,593
RGD:6480464
CTD
G
Bak1
BCL2-antagonist/killer 1
increases activity
ISO
20
5,255,954
5,264,593
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
multiple interactions
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
multiple interactions
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
affects localization
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
multiple interactions
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases activity
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases expression
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases expression
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
multiple interactions
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
multiple interactions
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases expression
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases expression
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases expression
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases expression
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
increases expression
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
increases phosphorylation
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
increases phosphorylation
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
affects response to substance
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
increases phosphorylation
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2l1
Bcl2-like 1
decreases response to substance
ISO
3
143,129,087
143,180,199
RGD:6480464
CTD
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
3
143,129,087
143,180,199
RGD:6480464
CTD
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
3
143,129,087
143,180,199
RGD:6480464
CTD
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
3
143,129,087
143,180,199
RGD:6480464
CTD
G
Bcl2l11
BCL2-like 11 (apoptosis facilitator)
multiple interactions
ISO
3
115,692,323
115,722,701
RGD:6480464
CTD
G
Bcl2l11
BCL2-like 11 (apoptosis facilitator)
increases degradation
ISO
3
115,692,323
115,722,701
RGD:6480464
CTD
G
Birc5
baculoviral IAP repeat-containing 5
decreases response to substance
ISO
RGD:6480464
CTD
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions
ISO
RGD:6480464
CTD
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
ISO
RGD:6480464
CTD
G
Birc5
baculoviral IAP repeat-containing 5
decreases response to substance
ISO
RGD:6480464
CTD
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
affects response to substance
ISO
3
105,063,018
105,116,145
RGD:6480464
CTD
G
Casp2
caspase 2
increases activity
ISO
4
70,029,728
70,047,164
RGD:6480464
CTD
G
Casp2
caspase 2
multiple interactions
ISO
4
70,029,728
70,047,164
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases cleavage
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases cleavage
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp8
caspase 8
increases activity
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
ISO
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
ISO
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
ISO
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
ISO
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Ccnb1
cyclin B1
multiple interactions
ISO
2
31,574,600
31,581,784
RGD:6480464
CTD
G
Cdk1
cyclin-dependent kinase 1
increases response to substance
ISO
20
20,018,044
20,044,030
RGD:6480464
CTD
G
Cdk1
cyclin-dependent kinase 1
increases activity
ISO
20
20,018,044
20,044,030
RGD:6480464
CTD
G
Cdk1
cyclin-dependent kinase 1
multiple interactions
ISO
20
20,018,044
20,044,030
RGD:6480464
CTD
G
Cdk1
cyclin-dependent kinase 1
multiple interactions
ISO
20
20,018,044
20,044,030
RGD:6480464
CTD
G
Cdk1
cyclin-dependent kinase 1
increases activity
ISO
20
20,018,044
20,044,030
RGD:6480464
CTD
G
Cdk2
cyclin dependent kinase 2
multiple interactions
ISO
7
2,000,196
2,007,682
RGD:6480464
CTD
G
Cdk2
cyclin dependent kinase 2
increases activity
ISO
7
2,000,196
2,007,682
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
decreases expression
ISO
5
108,908,749
108,916,380
RGD:6480464
CTD
G
Chfr
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
affects response to substance
ISO
12
46,651,265
46,684,689
RGD:6480464
CTD
G
Chfr
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
decreases response to substance
ISO
12
46,651,265
46,684,689
RGD:6480464
CTD
G
Ckm
creatine kinase, muscle
multiple interactions
ISO
1
78,762,202
78,772,681
RGD:6480464
CTD
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
increases secretion
ISO
10
39,665,850
39,667,831
RGD:6480464
CTD
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases expression
ISO
RGD:6480464
CTD
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
affects response to substance
ISO
6
2,548,224
2,553,767
RGD:6480464
CTD
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases response to substance
ISO
12
9,517,016
9,541,000
RGD:6480464
CTD
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
12
9,517,016
9,541,000
RGD:6480464
CTD
G
Dbi
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
multiple interactions
ISO
RGD:6480464
CTD
G
Dpyd
dihydropyrimidine dehydrogenase
multiple interactions
ISO
2
214,931,901
215,818,809
RGD:6480464
CTD
G
Dpyd
dihydropyrimidine dehydrogenase
decreases activity
ISO
2
214,931,901
215,818,809
RGD:6480464
CTD
G
Dpyd
dihydropyrimidine dehydrogenase
increases expression
ISO
2
214,931,901
215,818,809
RGD:6480464
CTD
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
14
97,617,358
97,788,211
RGD:6480464
CTD
G
Egfr
epidermal growth factor receptor
increases response to substance
ISO
14
97,617,358
97,788,211
RGD:6480464
CTD
G
Epo
erythropoietin
decreases response to substance
EXP
12
19,551,768
19,555,208
RGD:6480464
CTD
G
Erbb2
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
multiple interactions
ISO
10
87,219,157
87,242,919
RGD:6480464
CTD
G
Erbb2
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
multiple interactions
ISO
10
87,219,157
87,242,919
RGD:6480464
CTD
G
Erbb2
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
increases response to substance
ISO
10
87,219,157
87,242,919
RGD:6480464
CTD
G
F2r
coagulation factor II (thrombin) receptor
decreases response to substance
ISO
2
25,985,800
25,989,072
RGD:6480464
CTD
G
Fas
Fas (TNF receptor superfamily, member 6)
increases expression
ISO
1
238,259,443
238,274,745
RGD:6480464
CTD
G
Fas
Fas (TNF receptor superfamily, member 6)
increases expression
ISO
1
238,259,443
238,274,745
RGD:6480464
CTD
G
Fas
Fas (TNF receptor superfamily, member 6)
increases expression
ISO
1
238,259,443
238,274,745
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
multiple interactions
ISO
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
multiple interactions
ISO
4
96,649,941
96,652,243
RGD:6480464
CTD
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases response to substance
ISO
4
96,649,941
96,652,243
RGD:6480464
CTD
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
multiple interactions
ISO
4
161,282,215
161,286,090
RGD:6480464
CTD
G
Gstp1
glutathione S-transferase pi 1
increases response to substance
ISO
1
206,627,398
206,629,866
RGD:6480464
CTD
G
H2afx
H2A histone family, member X
multiple interactions
ISO
8
47,312,609
47,313,938
RGD:6480464
CTD
G
H2afx
H2A histone family, member X
increases expression
ISO
8
47,312,609
47,313,938
RGD:6480464
CTD
G
Hras
Harvey rat sarcoma virus oncogene
multiple interactions
ISO
1
201,385,705
201,388,987
RGD:6480464
CTD
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
multiple interactions
ISO
1
135,876,052
135,895,373
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
increases expression
ISO
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
increases expression
EXP
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il6
interleukin 6
increases expression
ISO
4
456,799
461,376
RGD:6480464
CTD
G
Il6
interleukin 6
increases expression
ISO
4
456,799
461,376
RGD:6480464
CTD
G
Jun
jun proto-oncogene
increases phosphorylation
ISO
5
115,358,166
115,361,259
RGD:6480464
CTD
G
Jun
jun proto-oncogene
multiple interactions
ISO
5
115,358,166
115,361,259
RGD:6480464
CTD
G
Kif12
kinesin family member 12
decreases response to substance
ISO
5
80,146,349
80,152,996
RGD:6480464
CTD
G
Kif5a
kinesin family member 5A
decreases response to substance
ISO
7
67,183,575
67,220,766
RGD:6480464
CTD
G
Kifc3
kinesin family member C3
decreases response to substance
ISO
19
10,335,789
10,354,364
RGD:6480464
CTD
G
Krt18
keratin 18
increases expression
ISO
RGD:6480464
CTD
G
Krt18
keratin 18
increases metabolic processing
ISO
RGD:6480464
CTD
G
Ldha
lactate dehydrogenase A
multiple interactions
ISO
1
97,403,077
97,412,547
RGD:6480464
CTD
G
Mad2l1
MAD2 mitotic arrest deficient-like 1 (yeast)
affects response to substance
ISO
4
96,380,039
96,386,042
RGD:6480464
CTD
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
11
85,968,732
86,030,387
RGD:6480464
CTD
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
11
85,968,732
86,030,387
RGD:6480464
CTD
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
1
185,935,044
185,941,245
RGD:6480464
CTD
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
1
185,935,044
185,941,245
RGD:6480464
CTD
G
Mcam
melanoma cell adhesion molecule
decreases response to substance
ISO
8
47,105,632
47,127,936
RGD:6480464
CTD
G
Mcl1
myeloid cell leukemia sequence 1
increases expression
ISO
RGD:6480464
CTD
G
Mcl1
myeloid cell leukemia sequence 1
multiple interactions
ISO
RGD:6480464
CTD
G
Mcm2
minichromosome maintenance complex component 2
multiple interactions
ISO
4
122,977,522
122,991,934
RGD:6480464
CTD
G
Mdm2
p53 E3 ubiquitin protein ligase
increases expression
ISO
7
56,996,694
57,020,926
RGD:6480464
CTD
G
Mdm2
p53 E3 ubiquitin protein ligase
increases expression
ISO
7
56,996,694
57,020,926
RGD:6480464
CTD
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
3
155,985,473
155,993,433
RGD:6480464
CTD
G
Nppb
natriuretic peptide B
increases expression
ISO
5
165,062,348
165,063,650
RGD:6480464
CTD
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
11
64,239,918
64,276,702
RGD:6480464
CTD
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
11
64,239,918
64,276,702
RGD:6480464
CTD
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
11
64,239,918
64,276,702
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Pgr
progesterone receptor
decreases expression
ISO
8
5,784,717
5,845,901
RGD:6480464
CTD
G
Pla2g4a
phospholipase A2, group IVA (cytosolic, calcium-dependent)
multiple interactions
ISO
13
64,135,729
64,280,815
RGD:6480464
CTD
G
Pomc
proopiomelanocortin
increases expression
EXP
6
26,931,969
26,937,789
RGD:6480464
CTD
G
Pomc
proopiomelanocortin
multiple interactions
EXP
6
26,931,969
26,937,789
RGD:6480464
CTD
G
Por
P450 (cytochrome) oxidoreductase
increases response to substance
ISO
12
22,078,629
22,097,301
RGD:6480464
CTD
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
4
151,492,220
151,617,331
RGD:6480464
CTD
G
Psip1
PC4 and SFRS1 interacting protein 1
increases cleavage
ISO
5
102,304,948
102,336,608
RGD:6480464
CTD
G
Ptges
prostaglandin E synthase
multiple interactions
ISO
3
9,946,194
9,957,538
RGD:6480464
CTD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
13
64,427,288
64,432,978
RGD:6480464
CTD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
13
64,427,288
64,432,978
RGD:6480464
CTD
G
Ptk2
protein tyrosine kinase 2
increases cleavage
ISO
7
110,933,298
111,084,554
RGD:6480464
CTD
G
Rad50
RAD50 homolog (S. cerevisiae)
multiple interactions
ISO
10
39,112,733
39,164,694
RGD:6480464
CTD
G
Raf1
v-raf-leukemia viral oncogene 1
increases expression
ISO
4
151,752,583
151,775,609
RGD:6480464
CTD
G
Rb1
retinoblastoma 1
multiple interactions
ISO
15
53,828,881
53,962,099
RGD:6480464
CTD
G
Rgs10
regulator of G-protein signaling 10
increases response to substance
ISO
1
187,622,488
187,664,295
RGD:6480464
CTD
G
Rgs17
regulator of G-protein signaling 17
increases response to substance
ISO
1
36,523,685
36,623,005
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
decreases expression
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
decreases expression
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnfrsf10b
tumor necrosis factor receptor superfamily, member 10b
multiple interactions
ISO
15
50,138,439
50,163,254
RGD:6480464
CTD
G
Tnfrsf10b
tumor necrosis factor receptor superfamily, member 10b
increases expression
ISO
15
50,138,439
50,163,254
RGD:6480464
CTD
G
Tnfsf10
tumor necrosis factor (ligand) superfamily, member 10
multiple interactions
ISO
2
113,204,303
113,221,550
RGD:6480464
CTD
G
Tp53
tumor protein p53
multiple interactions
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
decreases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
increases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
decreases ubiquitination
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
increases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
increases ubiquitination
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
multiple interactions
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
multiple interactions
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
multiple interactions
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
increases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
increases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
increases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
increases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
decreases response to substance
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
multiple interactions
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tp53
tumor protein p53
increases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Tubb5
tubulin, beta 5 class I
increases expression
ISO
20
3,060,224
3,090,776
RGD:6480464
CTD
G
Tubb5
tubulin, beta 5 class I
increases response to substance
ISO
20
3,060,224
3,090,776
RGD:6480464
CTD
G
Tubb5
tubulin, beta 5 class I
multiple interactions
ISO
20
3,060,224
3,090,776
RGD:6480464
CTD
G
Tubb5
tubulin, beta 5 class I
decreases response to substance
ISO
20
3,060,224
3,090,776
RGD:6480464
CTD
G
Tyms
thymidylate synthetase
multiple interactions
ISO
9
112,604,912
112,617,706
RGD:6480464
CTD
G
Tyms
thymidylate synthetase
decreases expression
ISO
9
112,604,912
112,617,706
RGD:6480464
CTD
G
Tyms
thymidylate synthetase
multiple interactions
ISO
9
112,604,912
112,617,706
RGD:6480464
CTD
G
Umps
uridine monophosphate synthetase
multiple interactions
ISO
11
68,619,835
68,630,244
RGD:6480464
CTD
G
Umps
uridine monophosphate synthetase
increases expression
ISO
11
68,619,835
68,630,244
RGD:6480464
CTD
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
multiple interactions
ISO
17
40,429,806
40,434,083
RGD:6480464
CTD
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
9
10,520,730
10,536,071
RGD:6480464
CTD
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
9
10,520,730
10,536,071
RGD:6480464
CTD
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
X
3,011,520
3,047,798
RGD:6480464
CTD
G
Xiap
X-linked inhibitor of apoptosis
decreases response to substance
ISO
X
3,011,520
3,047,798
RGD:6480464
CTD
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
X
3,011,520
3,047,798
RGD:6480464
CTD
G
Xrcc5
X-ray repair complementing defective repair in Chinese hamster cells 5
multiple interactions
ISO
9
71,472,459
71,581,936
RGD:6480464
CTD
G
Xrcc6
X-ray repair complementing defective repair in Chinese hamster cells 6
multiple interactions
ISO
7
120,401,944
120,422,923
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest